Stock screenerAll disclosures →
EDGAR →
GYRE
Conviction 20HealthcareScan · Thu, Jun 25, 2026GYRE$6.21-4.17%
ResistanceSupportVol 14Insider sellVol MA14 94.27K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price6.21
Change-4.17%
Gap+0.77%
Rel volume2.60×
Avg volume98.81K
Avg $ vol596.78K
SMA 206.01
SMA 506.74
SMA 2007.46
Price vs 50-7.91%
Price vs 200-16.76%
MA stackbearish
50/200 cross—
Supertrenddown · 6.54
RSI (14)49
MACD hist0.09
MACD cross—
Stoch %K / %D50 / 61
ADX (14)22
+DI / −DI27 / 16
RSI divergence—
MACD divergence—
ATR %+5.25%
ADR %5.28%
52w high8.87
52w low5.56
From 52w high-29.99%
Above 52w low+11.69%
New 52w highNo
SqueezeOff
Bollinger width14.71%
%B0.72
Donchian pos61.83%
Donchian high6.69
Donchian low5.44
AVWAP (52w high)7.41
vs AVWAP high-16.14%
AVWAP (52w low)6.10
vs AVWAP low+1.73%
OBV trendFlat
Chaikin MF (20)-0.21
Today vs 20d2.60×
Avg vol (14d)94.27K
Avg vol (20d)98.81K
Avg $ vol (20d)596.78K
Market cap602.55M
RS 3m (vs SPY)-18.89%
RS 6m (vs SPY)-16.85%
RS line new highNo
Trend template0/8
Technical rank33.0
1 week+2.14%
1 month+4.55%
3 months-13.51%
6 months-13.63%
1 year-18.40%
YTD-8.81%
P/E60.99
P/B5.95
P/S5.17
P/FCF-3347.48
EPS0.0200
Div yield—
ROE9.75%
ROA6.10%
Debt/Eq0.01
Current4.64
EV/EBITDA40.50
Gross margin87.38%
Net margin8.47%
Rev growth10.24%
EPS growth-44.80%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value565.66M
Revenue22.52M
Net income-9.86M
Gross profit28.94M
Free cash flow-180K
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out97.03M
Employees618
ListedTue, Oct 31, 2023
Free float17.84M
Float %18.4%
Short interest1.67M
Days to cover17.6d
Short volume61.5%
Squeeze score73 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction20 / 100
Pattern quality—
Tech rank33.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance7.38
Support5.56
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in GYRE
No recent disclosed trades by Congress in GYRE. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in GYRE · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Ye Weiguo Chief Operating Officer · Common Stock · 2026-06-18 | Sell | 3K | $19K | 2026-06-18 | 2026-06-22 |
Ye Weiguo Chief Operating Officer · Common Stock · 2026-06-18 | Exercise | 3K | $2K | 2026-06-18 | 2026-06-22 |
Ye Weiguo Chief Operating Officer · Stock Option (Right to Buy) · 2026-06-18 | Exercise | 3K | — | 2026-06-18 | 2026-06-22 |
Ye Weiguo Chief Operating Officer · Common Stock · 2026-06-10 | Exercise | 5K | $4K | 2026-06-10 | 2026-06-22 |
Ye Weiguo Chief Operating Officer · Common Stock · 2026-06-10 | Sell | 5K | $31K | 2026-06-10 | 2026-06-22 |
Ye Weiguo Chief Operating Officer · Stock Option (Right to Buy) · 2026-06-10 | Exercise | 5K | — | 2026-06-10 | 2026-06-22 |
Ye Weiguo Chief Operating Officer · Common Stock · 2026-06-09 | Exercise | 3K | $2K | 2026-06-09 | 2026-06-22 |
Ye Weiguo Chief Operating Officer · Common Stock · 2026-06-09 | Sell | 3K | $18K | 2026-06-09 | 2026-06-22 |
Ye Weiguo Chief Operating Officer · Stock Option (Right to Buy) · 2026-06-09 | Exercise | 3K | — | 2026-06-09 | 2026-06-22 |
Bergmann Joshua Benjamin GC and Corporate Secretary · Stock Option (Right to Buy) · 2026-06-08 | Grant | 50K | $0 | 2026-06-08 | 2026-06-10 |
SEC filings
EDGAR filings in GYRE · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.